Merck Starts Seven-Part High-Grade Bond Sale to Fund Terns Deal
Merck & Co. has kicked off an investment-grade bond sale to help finance its $6.7 billion acquisition of Terns Pharmaceuticals Inc.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.